Infertility Diagnosis, Treatment, and Fertility Preservation
Clinical medical policy describing medically necessary, unproven, and coding information for diagnosis, treatment, and fertility preservation services for members covered under UnitedHealthcare Commercial and Individual Exchange plans (with state exceptions).
Replaced reference to 'deoxynucleotidyl transferase- mediated dUTP nick end labeling assay (TUNEL)' with 'terminal deoxynucleotidyl transferase dUTP nick end labeling assay (TUNEL)'.
Removed definitions for Preimplantation Genetic Testing (PGT) and Therapeutic Donor Insemination (TDI).
Removed HCPCS code J3355 from Applicable Codes.
Updated Benefit Considerations, Clinical Evidence, and References sections to reflect the most current information.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.